Observations placeholder
Abraxane
Identifier
015630
Type of Spiritual Experience
Number of hallucinations: 27
Background
A description of the experience
Protein-bound paclitaxel is an injectable formulation of paclitaxel, a mitotic inhibitor drug used in the treatment of breast cancer, lung cancer and pancreatic cancer. In this formulation, paclitaxel is bonded to albumin as a delivery vehicle. It is sometimes called nab-paclitaxel (with the "nab" syllable derived from "nanoparticle albumin–bound"). It is sold in the United States under the trade name Abraxane.
This treatment was approved by the U.S. Food and Drug Administration (FDA) in January 2005 and the European Medicines Agency in January 2008 for breast cancer cases where cancer did not respond to other chemotherapy or has relapsed
On Jan, 11, 2017 6,235 people reported to have side effects when taking Abraxane.
Among them, 27 people (0.43%) have Hallucination
Time on Abraxane when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 16.67% | 83.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Abraxane :
| Female | Male | |
| Hallucination | 95.24% | 4.76% |
Age of people who have Hallucination when taking Abraxane :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.25% | 50.00% | 43.75% |